Stay updated on DVd vs Vd in Chinese Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the DVd vs Vd in Chinese Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the DVd vs Vd in Chinese Relapsed Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.SummaryDifference0.1%
- Check10 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of multiple myeloma has been removed from the content.SummaryDifference0.3%
- Check17 days agoChange DetectedThe web page has been updated to include a new facility name and location in Xi'an, China, along with a detailed reference to a clinical study involving daratumumab and multiple myeloma treatment. Several previous terms and references related to multiple myeloma and various drug classifications have been removed.SummaryDifference5%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to DVd vs Vd in Chinese Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DVd vs Vd in Chinese Relapsed Multiple Myeloma Clinical Trial page.